219 related articles for article (PubMed ID: 24365325)
1. Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study.
Laroche F; Coste J; Medkour T; Cottu PH; Pierga JY; Lotz JP; Beerblock K; Tournigand C; Declèves X; de Cremoux P; Bouhassira D; Perrot S
J Pain; 2014 Mar; 15(3):293-303. PubMed ID: 24365325
[TBL] [Abstract][Full Text] [Related]
2. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of arthralgia with estrogen deprivation.
Lintermans A; Neven P
Steroids; 2011 Jul; 76(8):781-5. PubMed ID: 21377484
[TBL] [Abstract][Full Text] [Related]
4. Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancer.
Henry NL; Conlon A; Kidwell KM; Griffith K; Smerage JB; Schott AF; Hayes DF; Williams DA; Clauw DJ; Harte SE
J Pain; 2014 May; 15(5):468-75. PubMed ID: 24462504
[TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibitor-associated arthralgia and/ or bone pain: frequency and characterization in non-clinical trial patients.
Presant CA; Bosserman L; Young T; Vakil M; Horns R; Upadhyaya G; Ebrahimi B; Yeon C; Howard F
Clin Breast Cancer; 2007 Oct; 7(10):775-8. PubMed ID: 18021478
[TBL] [Abstract][Full Text] [Related]
6. Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study.
Oh B; Kimble B; Costa DS; Davis E; McLean A; Orme K; Beith J
Acupunct Med; 2013 Sep; 31(3):264-71. PubMed ID: 23722951
[TBL] [Abstract][Full Text] [Related]
7. Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer.
Scarpa R; Atteno M; Peluso R; Costa L; Padula S; Di Minno D; Caso F; Iervolino S; Vitiello M; Del Puente A
J Clin Rheumatol; 2011 Jun; 17(4):169-72. PubMed ID: 21617557
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.
Laroche F; Perrot S; Medkour T; Cottu PH; Pierga JY; Lotz JP; Beerblock K; Tournigand C; Chauvenet L; Bouhassira D; Coste J
PLoS One; 2017; 12(11):e0187165. PubMed ID: 29117210
[TBL] [Abstract][Full Text] [Related]
9. Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer.
Servitja S; Nogués X; Prieto-Alhambra D; Martínez-García M; Garrigós L; Peña MJ; de Ramon M; Díez-Pérez A; Albanell J; Tusquets I
Breast; 2012 Feb; 21(1):95-101. PubMed ID: 21924904
[TBL] [Abstract][Full Text] [Related]
10. Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors.
Swenson KK; Nissen MJ; Henly SJ; Maybon L; Pupkes J; Zwicky K; Tsai ML; Shapiro AC
Oncol Nurs Forum; 2013 Nov; 40(6):549-57. PubMed ID: 24161633
[TBL] [Abstract][Full Text] [Related]
11. Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia.
Dizdar O; Ozçakar L; Malas FU; Harputluoglu H; Bulut N; Aksoy S; Ozisik Y; Altundag K
J Clin Oncol; 2009 Oct; 27(30):4955-60. PubMed ID: 19752344
[TBL] [Abstract][Full Text] [Related]
12. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
Crew KD; Capodice JL; Greenlee H; Brafman L; Fuentes D; Awad D; Yann Tsai W; Hershman DL
J Clin Oncol; 2010 Mar; 28(7):1154-60. PubMed ID: 20100963
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy.
Nyrop KA; Muss HB; Hackney B; Cleveland R; Altpeter M; Callahan LF
J Geriatr Oncol; 2014 Apr; 5(2):148-55. PubMed ID: 24495696
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of aromatase inhibitor associated arthralgia: known and potential candidate genes and associated biomarkers.
Borrie AE; Kim RB
Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):149-156. PubMed ID: 27635473
[TBL] [Abstract][Full Text] [Related]
15. Arthralgia during aromatase inhibitor treatment in early breast cancer patients: prevalence, impact, and recognition by healthcare providers.
Boonstra A; van Zadelhoff J; Timmer-Bonte A; Ottevanger PB; Beurskens CH; van Laarhoven HW
Cancer Nurs; 2013; 36(1):52-9. PubMed ID: 22495502
[TBL] [Abstract][Full Text] [Related]
16. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study.
Galantino ML; Callens ML; Cardena GJ; Piela NL; Mao JJ
Altern Ther Health Med; 2013; 19(6):38-44. PubMed ID: 24254037
[TBL] [Abstract][Full Text] [Related]
17. Treatment with Ruta graveolens 5CH and Rhus toxicodendron 9CH may reduce joint pain and stiffness linked to aromatase inhibitors in women with early breast cancer: results of a pilot observational study.
Karp JC; Sanchez C; Guilbert P; Mina W; Demonceaux A; Curé H
Homeopathy; 2016 Nov; 105(4):299-308. PubMed ID: 27914569
[TBL] [Abstract][Full Text] [Related]
18. Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors.
Mincey BA; Duh MS; Thomas SK; Moyneur E; Marynchencko M; Boyce SP; Mallett D; Perez EA
Clin Breast Cancer; 2006 Jun; 7(2):127-32. PubMed ID: 16800971
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?
Din OS; Dodwell D; Wakefield RJ; Coleman RE
Breast Cancer Res Treat; 2010 Apr; 120(3):525-38. PubMed ID: 20157776
[TBL] [Abstract][Full Text] [Related]
20. Joint pain and falls among women with breast cancer on aromatase inhibitors.
Basal C; Vertosick E; Gillis TA; Li Q; Bao T; Vickers A; Mao JJ
Support Care Cancer; 2019 Jun; 27(6):2195-2202. PubMed ID: 30306326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]